SEC Form 4 · accession 0001179110-18-001374

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Stephen R Fussell

Officer — Executive Vice President

Period of report

Jan 30, 2018

Accepted (ET)

Feb 1, 2018 · 5:48 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common shares without par value	Jan 30, 2018	M	149,600	$34.94	A	331,738	D
Common shares without par value	Jan 30, 2018	M	134,741	$39.12	A	466,479	D
Common shares without par value	Jan 30, 2018	M	104,642	$38.40	A	571,121	D
Common shares without par value	Jan 30, 2018	S	4,400	$62.65	D	566,721	D
Common shares without par value	Jan 30, 2018	S	500	$62.655	D	566,221	D
Common shares without par value	Jan 30, 2018	S	3,303	$62.66	D	562,918	D
Common shares without par value	Jan 30, 2018	S	300	$62.665	D	562,618	D
Common shares without par value	Jan 30, 2018	S	100	$62.675	D	562,518	D
Common shares without par value	Jan 31, 2018	S	1,000	$62.68	D	561,518	D
Common shares without par value	Jan 30, 2018	S	300	$62.685	D	561,218	D
Common shares without par value	Jan 30, 2018	S	300	$62.695	D	560,918	D
Common shares without par value	Jan 30, 2018	S	356	$62.70	D	560,562	D
Common shares without par value	Jan 30, 2018	S	500	$62.705	D	560,062	D
Common shares without par value	Jan 30, 2018	S	100	$62.71	D	559,962	D
Common shares without par value	Jan 30, 2018	S	9	$62.715	D	559,953	D
Common shares without par value	Jan 30, 2018	S	3,010	$62.725	D	556,943	D
Common shares without par value	Jan 30, 2018	S	5,903	$62.73	D	551,040	D
Common shares without par value	Jan 30, 2018	S	4,017	$62.735	D	547,023	D
Common shares without par value	Jan 30, 2018	S	8,400	$62.74	D	538,623	D
Common shares without par value	Jan 30, 2018	S	83,546	$62.745	D	455,077	D
Common shares without par value	Jan 30, 2018	S	2,615	$62.7475	D	452,462	D
Common shares without par value	Jan 30, 2018	S	53,383	$62.75	D	399,079	D
Common shares without par value	Jan 30, 2018	S	4,724	$62.755	D	394,355	D
Common shares without par value	Jan 30, 2018	S	3,703	$62.76	D	390,652	D
Common shares without par value	Jan 30, 2018	S	4,886	$62.765	D	385,766	D
Common shares without par value	Jan 30, 2018	S	800	$62.7675	D	384,966	D
Common shares without par value	Jan 30, 2018	S	6,986	$62.77	D	377,980	D
Common shares without par value	Jan 30, 2018	S	1,328	$62.775	D	376,652	D
Common shares without par value	Jan 30, 2018	S	800	$62.7775	D	375,852	D
Common shares without par value	Jan 30, 2018	S	32,143	$62.78	D	343,709	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F1	$34.94	Jan 30, 2018	M	149,600	D	Feb 15, 2016	Feb 14, 2023	Common shares	149,600	0	D
Option (right to buy)^F1	$39.12	Jan 30, 2018	M	134,741	D	Feb 21, 2017	Feb 20, 2024	Common shares	134,741	0	D
Option (right to buy)^F1	$38.40	Jan 30, 2018	M	104,642	D	Feb 19, 2017	Feb 18, 2026	Common shares	104,642	209,284	D

Explanation of responses

F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Form 1 of 4.